APA (7th ed.) Citation

Y, Y., R, R., L, K., A, K., RJ, W., & ZJ, Y. (2026). Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma. Molecular therapy. Oncology, 34(2), 201235. https://doi.org/10.1016/j.omton.2026.201235

Chicago Style (17th ed.) Citation

Y, Yang, Ronsley R, Kilburn L, Kim A, Wechsler-Reya RJ, and Yang ZJ. "Differentiation-inducing Triiodothyronine Enhances Chemotherapy and Suppresses Post-treatment Tumor Regrowth in Medulloblastoma." Molecular Therapy. Oncology 34, no. 2 (2026): 201235. https://doi.org/10.1016/j.omton.2026.201235.

MLA (9th ed.) Citation

Y, Yang, et al. "Differentiation-inducing Triiodothyronine Enhances Chemotherapy and Suppresses Post-treatment Tumor Regrowth in Medulloblastoma." Molecular Therapy. Oncology, vol. 34, no. 2, 2026, p. 201235, https://doi.org/10.1016/j.omton.2026.201235.